Tyra Biosciences (TYRA) Operating Expenses (2020 - 2026)
Tyra Biosciences' (TYRA) quarterly Operating Expenses came in at $42.0 million in Q1 2026, up 31.86% YoY from $31.8 million in Q1 2025, and up 15.01% on a QoQ basis from $36.5 million in Q4 2025.
Tyra Biosciences (TYRA) Operating Expenses (2020 - 2026) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Operating Expenses data on file, last reported at $42.0 million in Q1 2026.
- Quarterly Operating Expenses rose 31.86% year-over-year to $42.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $142.9 million (up 25.66% YoY) and the FY2025 annual result came in at $132.8 million, up 27.44% from the prior year.
- Operating Expenses rose to $42.0 million in Q1 2026, from $36.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $42.0 million in Q1 2026 to a low of $13.6 million in Q3 2022.
- A 5-year average of $24.6 million and a median of $24.0 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 252.27% — and 2023, when it fell 3.37%.
- Tracing TYRA's Operating Expenses over 5 years: stood at $15.0 million in 2022, then soared by 70.69% to $25.6 million in 2023, then increased by 16.03% to $29.7 million in 2024, then gained by 22.77% to $36.5 million in 2025, then advanced by 15.01% to $42.0 million in 2026.
- The last three Operating Expenses figures came in at $42.0 million (Q1 2026), $36.5 million (Q4 2025), and $32.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Tyra Biosciences | 1.51 Bn | 1.51 Bn | - | 49.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.00 Mn |
| Mar 31, 2026 | 42.00 Mn |
| Dec 31, 2025 | 36.52 Mn |
| Sep 30, 2025 | 32.94 Mn |
| Jun 30, 2025 | 31.45 Mn |
| Mar 31, 2025 | 31.85 Mn |
| Dec 31, 2024 | 29.74 Mn |
| Sep 30, 2024 | 28.60 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Mar 31, 2024 | 22.32 Mn |
| Dec 31, 2023 | 25.63 Mn |
| Sep 30, 2023 | 23.96 Mn |
| Jun 30, 2023 | 16.01 Mn |
| Mar 31, 2023 | 14.33 Mn |
| Dec 31, 2022 | 15.02 Mn |
| Sep 30, 2022 | 13.65 Mn |
| Jun 30, 2022 | 15.43 Mn |
| Mar 31, 2022 | 14.83 Mn |
| Dec 31, 2021 | 9.93 Mn |
| Sep 30, 2021 | 6.64 Mn |